##gff-version 3
##sequence-region Q9Y243 1 479
Q9Y243	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q9Y243	UniProtKB	Chain	2	479	.	.	.	ID=PRO_0000085611;Note=RAC-gamma serine/threonine-protein kinase	
Q9Y243	UniProtKB	Domain	5	107	.	.	.	Note=PH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00145	
Q9Y243	UniProtKB	Domain	148	405	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9Y243	UniProtKB	Domain	406	479	.	.	.	Note=AGC-kinase C-terminal	
Q9Y243	UniProtKB	Nucleotide binding	154	162	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9Y243	UniProtKB	Active site	271	271	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
Q9Y243	UniProtKB	Binding site	177	177	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q9Y243	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q9Y243	UniProtKB	Modified residue	305	305	.	.	.	Note=Phosphothreonine%3B by PDPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9512493;Dbxref=PMID:9512493	
Q9Y243	UniProtKB	Modified residue	447	447	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9Y243	UniProtKB	Modified residue	472	472	.	.	.	Note=Phosphoserine%3B by PKC/PRKCZ;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12162751;Dbxref=PMID:12162751	
Q9Y243	UniProtKB	Glycosylation	302	302	.	.	.	Note=O-linked (GlcNAc) threonine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9Y243	UniProtKB	Glycosylation	309	309	.	.	.	Note=O-linked (GlcNAc) threonine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9Y243	UniProtKB	Disulfide bond	59	76	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9Y243	UniProtKB	Disulfide bond	293	307	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9Y243	UniProtKB	Alternative sequence	452	479	.	.	.	ID=VSP_004947;Note=In isoform 2. YDEDGMDCMDNERRPHFPQFSYSASGRE->CQQSDCGMLGNWKK;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:11230166,ECO:0000303|PubMed:11387345,ECO:0000303|PubMed:15489334;Dbxref=PMID:11230166,PMID:11387345,PMID:15489334	
Q9Y243	UniProtKB	Natural variant	17	17	.	.	.	ID=VAR_065830;Note=In MPPH2 and melanoma%3B results in activation of AKT. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18813315,ECO:0000269|PubMed:22500628,ECO:0000269|PubMed:22729223;Dbxref=dbSNP:rs397514606,PMID:18813315,PMID:22500628,PMID:22729223	
Q9Y243	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_040358;Note=In a glioblastoma multiforme sample%3B somatic mutation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs1402272180,PMID:17344846	
Q9Y243	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_069260;Note=In MPPH2. N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:22729224,ECO:0000269|PubMed:23745724;Dbxref=dbSNP:rs397514605,PMID:22729224,PMID:23745724	
Q9Y243	UniProtKB	Natural variant	465	465	.	.	.	ID=VAR_069261;Note=In MPPH2%3B disease phenotype overlaps with megalencephaly-capillary malformation syndrome. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22729224;Dbxref=dbSNP:rs587776935,PMID:22729224	
Q9Y243	UniProtKB	Mutagenesis	305	305	.	.	.	Note=No activation after pervanadate treatment. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11387345;Dbxref=PMID:11387345	
Q9Y243	UniProtKB	Mutagenesis	305	305	.	.	.	Note=2-fold increase of phosphorylation steady state level%2C no activation after pervanadate treatment. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11387345;Dbxref=PMID:11387345	
Q9Y243	UniProtKB	Mutagenesis	447	447	.	.	.	Note=No effect. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11387345;Dbxref=PMID:11387345	
Q9Y243	UniProtKB	Mutagenesis	447	447	.	.	.	Note=No effect. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11387345;Dbxref=PMID:11387345	
Q9Y243	UniProtKB	Mutagenesis	472	472	.	.	.	Note=67%25 decrease of activity after pervanadate treatment. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10092583;Dbxref=PMID:10092583	
Q9Y243	UniProtKB	Mutagenesis	472	472	.	.	.	Note=1.4-fold increase of phosphorylation steady state level%2C 50%25 decrease of activity after pervanadate treatment. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10092583;Dbxref=PMID:10092583	
Q9Y243	UniProtKB	Sequence conflict	279	279	.	.	.	Note=L->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9Y243	UniProtKB	Beta strand	6	15	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	17	30	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	33	41	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Helix	44	46	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	51	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	60	64	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	66	68	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	71	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Turn	80	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Beta strand	84	88	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
Q9Y243	UniProtKB	Helix	92	113	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2X18	
